As of 11:53:22 AM EDT. Market Open. CAMBRIDGE, Mass. & SALISBURY, England, March 25, 2025--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the completion of enrollment in the open ...
Shares of NASDAQ:KALV opened at $11.93 on Friday. The business’s 50 day moving average is $10.56 and its 200 day moving average is $10.25. The stock has a market cap of $593.11 million, a P/E ...
SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the ... Median time to treatment with sebetralstat: 11.5 minutes after attack onset Median ...
Shares of KALV stock opened at $11.92 on Friday. The firm’s 50 day moving average price is $9.31 and its 200-day moving average price is $10.31. KalVista Pharmaceuticals has a one year low of $7 ...
$KALV insiders have traded $KALV stock on the open market 20 times in the past 6 months. Of those trades, 8 have been purchases and 12 have been sales. Here’s a ...
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
CAMBRIDGE, Mass. & SALISBURY, England, March 03, 2025--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of novel sebetralstat data related to laryngeal hereditary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback